T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.81B |
| 2 |
XYZ
Block Inc
XYZ
|
+$1.46B |
| 3 |
Accenture
ACN
|
+$1.23B |
| 4 |
Gilead Sciences
GILD
|
+$1.15B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.06B |
| 3 |
Tesla
TSLA
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.72B |
| 5 |
Amazon
AMZN
|
+$1.59B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.44% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.3% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Universal Health Services
UHS
$10.1B
| $15.8M | ﹤0.01% |
84,008
+625
| +0.7% | +$114K |
|
1002
Amphastar Pharmaceuticals
AMPH
$858M
| $15.7M | ﹤0.01% |
541,221
-25,435
| -4% | -$812K |
|
1003
Flutter Entertainment
FLUT
$17.1B
| $15.7M | ﹤0.01% |
70,786
+7,706
| +12% | +$2M |
|
1004
A.O. Smith
AOS
$8.49B
| $15.6M | ﹤0.01% |
238,307
-1,485
| -0.6% | -$100K |
|
1005
FormFactor
FORM
$10.3B
| $15.5M | ﹤0.01% |
547,717
+2,826
| +0.5% | +$104K |
|
1006
Erie Indemnity
ERIE
$13.4B
| $15.4M | ﹤0.01% |
36,839
+478
| +1% | +$195K |
|
1007
TG Therapeutics
TGTX
$7.34B
| $15.4M | ﹤0.01% |
390,528
+93,427
| +31% | +$3.14M |
|
1008
Bright Horizons
BFAM
$3.85B
| $15.4M | ﹤0.01% |
121,181
-258,078
| -68% | -$31.7M |
|
1009
First Citizens BancShares
FCNCA
$25.6B
| $15.4M | ﹤0.01% |
8,299
+201
| +2% | +$409K |
|
1010
Bunge Global
BG
$21.7B
| $15.4M | ﹤0.01% |
200,977
-3,056
| -1% | -$229K |
|
1011
Solventum
SOLV
$14.7B
| $15.3M | ﹤0.01% |
201,041
+499
| +0.2% | +$37.2K |
|
|
ITCI
1012
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $15.2M | ﹤0.01% |
115,424
-474,482
| -80% | -$59.1M |
|
1013
PennyMac Financial
PFSI
$4.13B
| $15.2M | ﹤0.01% |
152,078
+17,643
| +13% | +$1.81M |
|
1014
Paycom
PAYC
$10.1B
| $15.2M | ﹤0.01% |
69,621
+363
| +0.5% | +$76.6K |
|
1015
Sarepta Therapeutics
SRPT
$1.95B
| $15.2M | ﹤0.01% |
238,248
-3,415
| -1% | -$359K |
|
1016
Pinnacle West Capital
PNW
$12.2B
| $15.1M | ﹤0.01% |
158,616
+2,028
| +1% | +$181K |
|
|
IPG
1017
DELISTED
Interpublic Group of Companies
IPG
| $14.9M | ﹤0.01% |
549,239
+20,202
| +4% | +$554K |
|
1018
Leonardo DRS
DRS
$11.9B
| $14.9M | ﹤0.01% |
453,560
-382,733
| -46% | -$12.6M |
|
1019
Skyworks Solutions
SWKS
$10.5B
| $14.9M | ﹤0.01% |
230,731
+1,974
| +0.9% | +$150K |
|
1020
iShares Core MSCI EAFE ETF
IEFA
$196B
| $14.9M | ﹤0.01% |
196,585
-206,394
| -51% | -$15.4M |
|
1021
Interactive Brokers
IBKR
$41.4B
| $14.8M | ﹤0.01% |
357,288
+95,792
| +37% | +$4.75M |
|
1022
Eastman Chemical
EMN
$8.43B
| $14.7M | ﹤0.01% |
166,544
+1,468
| +0.9% | +$139K |
|
1023
Host Hotels & Resorts
HST
$15.6B
| $14.5M | ﹤0.01% |
1,021,599
-3,726,586
| -78% | -$60.4M |
|
1024
Essent Group
ESNT
$6.23B
| $14.5M | ﹤0.01% |
250,956
+7,046
| +3% | +$400K |
|
1025
Berkshire Hathaway Class A
BRK.A
$1.09T
| $14.4M | ﹤0.01% |
18
| – | – |
|
Similar funds
T. Rowe Price Associates's Q1 2025 Portfolio in Review
As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
- T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
- T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
- T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
- T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
- T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.
Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.